0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Autologous Biologics Market Research Report 2022
Published Date: August 2022
|
Report Code: QYRE-Auto-1Q11891
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Autologous Biologics Market Research Report 2022

Global Autologous Biologics Market Research Report 2022

Code: QYRE-Auto-1Q11891
Report
August 2022
93 Pages
QYResearch
Region: Global
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Highlights

The global Autologous Biologics market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.

North American market for Autologous Biologics is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

Asia-Pacific market for Autologous Biologics is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.

The major global manufacturers of Autologous Biologics include Vericel Corporation, BioTime, Inc., Pharmicell Co., BrainStorm Cell Therapeutics, Opexa Therapeutics, Inc, Pharmicell Co., Inc, Neostem, Dendreon Corporation and Regenexx and etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.

The global market for Autologous Biologics in Hospitals is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Adipose Tissue, which accounted for % of the global market of Autologous Biologics in 2021, is expected to reach million US$ by 2028, growing at a revised CAGR of % from 2022 to 2028.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Autologous Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autologous Biologics.
The Autologous Biologics market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Autologous Biologics market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Autologous Biologics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Vericel Corporation
BioTime, Inc.
Pharmicell Co.
BrainStorm Cell Therapeutics
Opexa Therapeutics, Inc
Pharmicell Co., Inc
Neostem
Dendreon Corporation
Regenexx
Cytori Therapeutics
Product Type Insights
Global markets are presented by Autologous Biologics type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Autologous Biologics are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Autologous Biologics segment by Type

Adipose Tissue
Plasma
Others
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Autologous Biologics market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Autologous Biologics market.

Autologous Biologics segment by Application

Hospitals
Ambulatory Centers
Research Centers
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Autologous Biologics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Autologous Biologics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Autologous Biologics and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Autologous Biologics industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Autologous Biologics.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Autologous Biologics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Autologous Biologics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Analysis of sales channel, distributors and customers
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 11: The main points and conclusions of the report.
1 Autologous Biologics Market Overview
1.1 Product Overview and Scope of Autologous Biologics
1.2 Autologous Biologics Segment by Type
1.2.1 Global Autologous Biologics Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Adipose Tissue
1.2.3 Plasma
1.2.4 Others
1.3 Autologous Biologics Segment by Application
1.3.1 Global Autologous Biologics Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals
1.3.3 Ambulatory Centers
1.3.4 Research Centers
1.4 Global Autologous Biologics Market Size Estimates and Forecasts
1.4.1 Global Autologous Biologics Revenue 2017-2028
1.4.2 Global Autologous Biologics Sales 2017-2028
1.4.3 Autologous Biologics Market Size by Region: 2017 Versus 2021 Versus 2028
2 Autologous Biologics Market Competition by Manufacturers
2.1 Global Autologous Biologics Sales Market Share by Manufacturers (2017-2022)
2.2 Global Autologous Biologics Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Autologous Biologics Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Autologous Biologics Manufacturing Sites, Area Served, Product Type
2.5 Autologous Biologics Market Competitive Situation and Trends
2.5.1 Autologous Biologics Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Autologous Biologics Players Market Share by Revenue
2.5.3 Global Autologous Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Autologous Biologics Retrospective Market Scenario by Region
3.1 Global Autologous Biologics Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Autologous Biologics Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Autologous Biologics Market Facts & Figures by Country
3.3.1 North America Autologous Biologics Sales by Country
3.3.2 North America Autologous Biologics Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Autologous Biologics Market Facts & Figures by Country
3.4.1 Europe Autologous Biologics Sales by Country
3.4.2 Europe Autologous Biologics Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Autologous Biologics Market Facts & Figures by Region
3.5.1 Asia Pacific Autologous Biologics Sales by Region
3.5.2 Asia Pacific Autologous Biologics Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Autologous Biologics Market Facts & Figures by Country
3.6.1 Latin America Autologous Biologics Sales by Country
3.6.2 Latin America Autologous Biologics Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Autologous Biologics Market Facts & Figures by Country
3.7.1 Middle East and Africa Autologous Biologics Sales by Country
3.7.2 Middle East and Africa Autologous Biologics Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Autologous Biologics Historic Market Analysis by Type
4.1 Global Autologous Biologics Sales Market Share by Type (2017-2022)
4.2 Global Autologous Biologics Revenue Market Share by Type (2017-2022)
4.3 Global Autologous Biologics Price by Type (2017-2022)
5 Global Autologous Biologics Historic Market Analysis by Application
5.1 Global Autologous Biologics Sales Market Share by Application (2017-2022)
5.2 Global Autologous Biologics Revenue Market Share by Application (2017-2022)
5.3 Global Autologous Biologics Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Vericel Corporation
6.1.1 Vericel Corporation Corporation Information
6.1.2 Vericel Corporation Description and Business Overview
6.1.3 Vericel Corporation Autologous Biologics Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Vericel Corporation Autologous Biologics Product Portfolio
6.1.5 Vericel Corporation Recent Developments/Updates
6.2 BioTime, Inc.
6.2.1 BioTime, Inc. Corporation Information
6.2.2 BioTime, Inc. Description and Business Overview
6.2.3 BioTime, Inc. Autologous Biologics Sales, Revenue and Gross Margin (2017-2022)
6.2.4 BioTime, Inc. Autologous Biologics Product Portfolio
6.2.5 BioTime, Inc. Recent Developments/Updates
6.3 Pharmicell Co.
6.3.1 Pharmicell Co. Corporation Information
6.3.2 Pharmicell Co. Description and Business Overview
6.3.3 Pharmicell Co. Autologous Biologics Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Pharmicell Co. Autologous Biologics Product Portfolio
6.3.5 Pharmicell Co. Recent Developments/Updates
6.4 BrainStorm Cell Therapeutics
6.4.1 BrainStorm Cell Therapeutics Corporation Information
6.4.2 BrainStorm Cell Therapeutics Description and Business Overview
6.4.3 BrainStorm Cell Therapeutics Autologous Biologics Sales, Revenue and Gross Margin (2017-2022)
6.4.4 BrainStorm Cell Therapeutics Autologous Biologics Product Portfolio
6.4.5 BrainStorm Cell Therapeutics Recent Developments/Updates
6.5 Opexa Therapeutics, Inc
6.5.1 Opexa Therapeutics, Inc Corporation Information
6.5.2 Opexa Therapeutics, Inc Description and Business Overview
6.5.3 Opexa Therapeutics, Inc Autologous Biologics Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Opexa Therapeutics, Inc Autologous Biologics Product Portfolio
6.5.5 Opexa Therapeutics, Inc Recent Developments/Updates
6.6 Pharmicell Co., Inc
6.6.1 Pharmicell Co., Inc Corporation Information
6.6.2 Pharmicell Co., Inc Description and Business Overview
6.6.3 Pharmicell Co., Inc Autologous Biologics Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Pharmicell Co., Inc Autologous Biologics Product Portfolio
6.6.5 Pharmicell Co., Inc Recent Developments/Updates
6.7 Neostem
6.6.1 Neostem Corporation Information
6.6.2 Neostem Description and Business Overview
6.6.3 Neostem Autologous Biologics Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Neostem Autologous Biologics Product Portfolio
6.7.5 Neostem Recent Developments/Updates
6.8 Dendreon Corporation
6.8.1 Dendreon Corporation Corporation Information
6.8.2 Dendreon Corporation Description and Business Overview
6.8.3 Dendreon Corporation Autologous Biologics Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Dendreon Corporation Autologous Biologics Product Portfolio
6.8.5 Dendreon Corporation Recent Developments/Updates
6.9 Regenexx
6.9.1 Regenexx Corporation Information
6.9.2 Regenexx Description and Business Overview
6.9.3 Regenexx Autologous Biologics Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Regenexx Autologous Biologics Product Portfolio
6.9.5 Regenexx Recent Developments/Updates
6.10 Cytori Therapeutics
6.10.1 Cytori Therapeutics Corporation Information
6.10.2 Cytori Therapeutics Description and Business Overview
6.10.3 Cytori Therapeutics Autologous Biologics Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Cytori Therapeutics Autologous Biologics Product Portfolio
6.10.5 Cytori Therapeutics Recent Developments/Updates
7 Autologous Biologics Manufacturing Cost Analysis
7.1 Autologous Biologics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Autologous Biologics
7.4 Autologous Biologics Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Autologous Biologics Distributors List
8.3 Autologous Biologics Customers
9 Autologous Biologics Market Dynamics
9.1 Autologous Biologics Industry Trends
9.2 Autologous Biologics Market Drivers
9.3 Autologous Biologics Market Challenges
9.4 Autologous Biologics Market Restraints
10 Global Market Forecast
10.1 Autologous Biologics Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Autologous Biologics by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Autologous Biologics by Type (2023-2028)
10.2 Autologous Biologics Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Autologous Biologics by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Autologous Biologics by Application (2023-2028)
10.3 Autologous Biologics Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Autologous Biologics by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Autologous Biologics by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
    Table 1. Global Autologous Biologics Sales Growth Rate Comparison by Type (2022-2028) & (Kg) & (US$ Million)
    Table 2. Global Autologous Biologics Sales Growth Rate Comparison by Application (2022-2028) & (Kg) & (US$ Million)
    Table 3. Global Autologous Biologics Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Autologous Biologics Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Autologous Biologics Sales (Kg) of Key Manufacturers (2017-2022)
    Table 6. Global Autologous Biologics Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Autologous Biologics Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Autologous Biologics Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Autologous Biologics Average Price (US$/Kg) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Autologous Biologics Manufacturing Sites and Area Served
    Table 11. Manufacturers Autologous Biologics Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Autologous Biologics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autologous Biologics as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Autologous Biologics Sales by Region (2017-2022) & (Kg)
    Table 16. Global Autologous Biologics Sales Market Share by Region (2017-2022)
    Table 17. Global Autologous Biologics Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Autologous Biologics Revenue Market Share by Region (2017-2022)
    Table 19. North America Autologous Biologics Sales by Country (2017-2022) & (Kg)
    Table 20. North America Autologous Biologics Sales Market Share by Country (2017-2022)
    Table 21. North America Autologous Biologics Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Autologous Biologics Revenue Market Share by Country (2017-2022)
    Table 23. Europe Autologous Biologics Sales by Country (2017-2022) & (Kg)
    Table 24. Europe Autologous Biologics Sales Market Share by Country (2017-2022)
    Table 25. Europe Autologous Biologics Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Autologous Biologics Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Autologous Biologics Sales by Region (2017-2022) & (Kg)
    Table 28. Asia Pacific Autologous Biologics Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Autologous Biologics Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Autologous Biologics Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Autologous Biologics Sales by Country (2017-2022) & (Kg)
    Table 32. Latin America Autologous Biologics Sales Market Share by Country (2017-2022)
    Table 33. Latin America Autologous Biologics Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Autologous Biologics Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Autologous Biologics Sales by Country (2017-2022) & (Kg)
    Table 36. Middle East and Africa Autologous Biologics Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Autologous Biologics Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Autologous Biologics Revenue Market Share by Country (2017-2022)
    Table 39. Global Autologous Biologics Sales by Type (2017-2022) & (Kg)
    Table 40. Global Autologous Biologics Sales Market Share by Type (2017-2022)
    Table 41. Global Autologous Biologics Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Autologous Biologics Revenue Share by Type (2017-2022)
    Table 43. Global Autologous Biologics Price by Type (2017-2022) & (US$/Kg)
    Table 44. Global Autologous Biologics Sales (Kg) by Application (2017-2022)
    Table 45. Global Autologous Biologics Sales Market Share by Application (2017-2022)
    Table 46. Global Autologous Biologics Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Autologous Biologics Revenue Share by Application (2017-2022)
    Table 48. Global Autologous Biologics Price by Application (2017-2022) & (US$/Kg)
    Table 49. Vericel Corporation Corporation Information
    Table 50. Vericel Corporation Description and Business Overview
    Table 51. Vericel Corporation Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 52. Vericel Corporation Autologous Biologics Product
    Table 53. Vericel Corporation Recent Developments/Updates
    Table 54. BioTime, Inc. Corporation Information
    Table 55. BioTime, Inc. Description and Business Overview
    Table 56. BioTime, Inc. Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 57. BioTime, Inc. Autologous Biologics Product
    Table 58. BioTime, Inc. Recent Developments/Updates
    Table 59. Pharmicell Co. Corporation Information
    Table 60. Pharmicell Co. Description and Business Overview
    Table 61. Pharmicell Co. Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 62. Pharmicell Co. Autologous Biologics Product
    Table 63. Pharmicell Co. Recent Developments/Updates
    Table 64. BrainStorm Cell Therapeutics Corporation Information
    Table 65. BrainStorm Cell Therapeutics Description and Business Overview
    Table 66. BrainStorm Cell Therapeutics Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 67. BrainStorm Cell Therapeutics Autologous Biologics Product
    Table 68. BrainStorm Cell Therapeutics Recent Developments/Updates
    Table 69. Opexa Therapeutics, Inc Corporation Information
    Table 70. Opexa Therapeutics, Inc Description and Business Overview
    Table 71. Opexa Therapeutics, Inc Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 72. Opexa Therapeutics, Inc Autologous Biologics Product
    Table 73. Opexa Therapeutics, Inc Recent Developments/Updates
    Table 74. Pharmicell Co., Inc Corporation Information
    Table 75. Pharmicell Co., Inc Description and Business Overview
    Table 76. Pharmicell Co., Inc Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 77. Pharmicell Co., Inc Autologous Biologics Product
    Table 78. Pharmicell Co., Inc Recent Developments/Updates
    Table 79. Neostem Corporation Information
    Table 80. Neostem Description and Business Overview
    Table 81. Neostem Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 82. Neostem Autologous Biologics Product
    Table 83. Neostem Recent Developments/Updates
    Table 84. Dendreon Corporation Corporation Information
    Table 85. Dendreon Corporation Description and Business Overview
    Table 86. Dendreon Corporation Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 87. Dendreon Corporation Autologous Biologics Product
    Table 88. Dendreon Corporation Recent Developments/Updates
    Table 89. Regenexx Corporation Information
    Table 90. Regenexx Description and Business Overview
    Table 91. Regenexx Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 92. Regenexx Autologous Biologics Product
    Table 93. Regenexx Recent Developments/Updates
    Table 94. Cytori Therapeutics Corporation Information
    Table 95. Cytori Therapeutics Description and Business Overview
    Table 96. Cytori Therapeutics Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 97. Cytori Therapeutics Autologous Biologics Product
    Table 98. Cytori Therapeutics Recent Developments/Updates
    Table 99. Production Base and Market Concentration Rate of Raw Material
    Table 100. Key Suppliers of Raw Materials
    Table 101. Autologous Biologics Distributors List
    Table 102. Autologous Biologics Customers List
    Table 103. Autologous Biologics Market Trends
    Table 104. Autologous Biologics Market Drivers
    Table 105. Autologous Biologics Market Challenges
    Table 106. Autologous Biologics Market Restraints
    Table 107. Global Autologous Biologics Sales Forecast by Type (2023-2028) & (Kg)
    Table 108. Global Autologous Biologics Sales Market Share Forecast by Type (2023-2028)
    Table 109. Global Autologous Biologics Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 110. Global Autologous Biologics Revenue Market Share Forecast by Type (2023-2028)
    Table 111. Global Autologous Biologics Sales Forecast by Application (2023-2028) & (Kg)
    Table 112. Global Autologous Biologics Sales Market Share Forecast by Application (2023-2028)
    Table 113. Global Autologous Biologics Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 114. Global Autologous Biologics Revenue Market Share Forecast by Application (2023-2028)
    Table 115. Global Autologous Biologics Sales Forecast by Region (2023-2028) & (Kg)
    Table 116. Global Autologous Biologics Sales Market Share Forecast by Region (2023-2028)
    Table 117. Global Autologous Biologics Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 118. Global Autologous Biologics Revenue Market Share Forecast by Region (2023-2028)
    Table 119. Research Programs/Design for This Report
    Table 120. Key Data Information from Secondary Sources
    Table 121. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Autologous Biologics
    Figure 2. Global Autologous Biologics Market Share by Type in 2021 & 2028
    Figure 3. Adipose Tissue Product Picture
    Figure 4. Plasma Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Autologous Biologics Market Share by Application in 2021 & 2028
    Figure 7. Hospitals
    Figure 8. Ambulatory Centers
    Figure 9. Research Centers
    Figure 10. Global Autologous Biologics Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Autologous Biologics Market Size (2017-2028) & (US$ Million)
    Figure 12. Global Autologous Biologics Sales (2017-2028) & (Kg)
    Figure 13. Autologous Biologics Sales Share by Manufacturers in 2021
    Figure 14. Global Autologous Biologics Revenue Share by Manufacturers in 2021
    Figure 15. The Global 5 and 10 Largest Autologous Biologics Players: Market Share by Revenue in 2021
    Figure 16. Autologous Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 17. Global Autologous Biologics Sales Market Share by Region (2017-2022)
    Figure 18. Global Autologous Biologics Sales Market Share by Region in 2021
    Figure 19. Global Autologous Biologics Revenue Market Share by Region (2017-2022)
    Figure 20. Global Autologous Biologics Revenue Market Share by Region in 2021
    Figure 21. United States Autologous Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. Canada Autologous Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. Germany Autologous Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. France Autologous Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. U.K. Autologous Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Italy Autologous Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Russia Autologous Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. China Autologous Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. Japan Autologous Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. South Korea Autologous Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. India Autologous Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Australia Autologous Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. China Taiwan Autologous Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Indonesia Autologous Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Thailand Autologous Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Malaysia Autologous Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Mexico Autologous Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Brazil Autologous Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Argentina Autologous Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Colombia Autologous Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Turkey Autologous Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Saudi Arabia Autologous Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. UAE Autologous Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Sales Market Share of Autologous Biologics by Type (2017-2022)
    Figure 45. Manufacturing Cost Structure of Autologous Biologics
    Figure 46. Manufacturing Process Analysis of Autologous Biologics
    Figure 47. Autologous Biologics Industrial Chain Analysis
    Figure 48. Channels of Distribution
    Figure 49. Distributors Profiles
    Figure 50. Bottom-up and Top-down Approaches for This Report
    Figure 51. Data Triangulation
    Figure 52. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$2900
This license allows only one user to access the PDF.

Electronic (PDF)
$4350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$5800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano String
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Marine Bio Products Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Marine Bio Products Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-34E5025
Fri Sep 23 00:00:00 UTC 2022

Add to Cart

Global Potassium Tert Butoxide Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Potassium Tert-Butoxide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-25B5115
Fri Sep 23 00:00:00 UTC 2022

Add to Cart

Global Medical Specialty Enzymes Market Size Manufacturers Supply Chain Sales Channel and Clients 2022 2028
Global Medical Specialty Enzymes Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-13Z12247
Fri Sep 23 00:00:00 UTC 2022

Add to Cart

China Aptamers Market Report Forecast 2021 2027
Global Aptamers Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-07
Fri Sep 23 00:00:00 UTC 2022

Add to Cart